PING AN BIOMEDICAL CO LTD (PASW) Stock Income Statement
USA - NASDAQ:PASW - KYG5880S1057 - Common Stock
0.775 USD
+0.01 (+1.31%)
| 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|
| Revenue | 87.62M | 82.56M | 114.55M | |||
| Cost Of Goods | 82.21M | 78.32M | 100.40M | |||
| Gross Profit | 5.42M | 4.24M | 14.14M | |||
| Operating Expenses | 5.42M | 3.63M | 3.33M | |||
| Selling, General, and Administrative Expenses | 5.42M | 3.63M | 3.33M | |||
| Operating Income | -2.00K | 612.50K | 10.82M | |||
| Interest Income/Expense | -703.20K | -1.58M | -1.52M | |||
| Other Income/Expense | 22.60K | 1.01M | 334.00K | |||
| Income Before Taxes | -682.70K | 41.70K | 9.63M | |||
| Income Tax | 601.50K | 1.04M | 2.40M | |||
| Net Income | -1.28M | -993.90K | 7.23M | |||
| EBITDA | 8.20K | 645.30K | 11.23M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -0.06 | -0.05 | 0.35 | |||
| Statistics | ||||||
| Gross Profit Margin | 6.18% | 5.14% | 12.35% | |||
| Profit Margin | -1.47% | -1.20% | 6.31% | |||
| Operating Profit Margin | -0.00% | 0.74% | 9.44% | |||
All data in CNY